Related Experiment Video
Updated: Oct 19, 2025

07:56
Genome Editing in Mammalian Cell Lines using CRISPR-Cas
Published on: April 11, 2019
22.3K
AddTag, a two-step approach with supporting software package that facilitates CRISPR/Cas-mediated precision genome
Thaddeus D Seher1, Namkha Nguyen1, Diana Ramos2
1Quantitative and Systems Biology Graduate Program, University of California, Merced, Merced, CA 95343, USA.
G3 (Bethesda, Md.)
|September 20, 2021
Summary
This study introduces a two-step genome editing method to overcome CRISPR/Cas limitations. The AddTag approach enables precise editing of small genomic features at any locus, expanding gene editing capabilities.
Area of Science:
- Molecular Biology
- Genetics
- Bioengineering
Background:
- CRISPR/Cas genome editing offers powerful genetic engineering capabilities but faces limitations due to targeting constraints.
- Precision editing of small genomic features is challenging because DNA sequence length affects the probability of overlapping unique target sites.
Purpose of the Study:
- To introduce a novel two-step genome editing strategy that overcomes CRISPR/Cas targeting limitations.
- To enable precision genome editing of small genomic elements at virtually any locus.
Main Methods:
- A two-step genome editing strategy involving an "AddTag" sequence replacement.
- The AddTag sequence is first inserted at the locus of interest and then replaced with a desired engineered sequence.
- Demonstration in Candida albicans by editing transcription factor binding sites.
Main Results:
- The AddTag approach effectively eliminates CRISPR/Cas targeting constraints.
- Enabled precise editing of single base-pair genomic elements.
- Successfully edited transcription factor binding sites in Candida albicans that were previously inaccessible.
- Demonstrated utility for combinatorial genome editing and gene complementation analysis.
- Developed a software package to automate AddTag editing design.
Conclusions:
- The AddTag strategy significantly expands the scope and precision of CRISPR/Cas genome editing.
- This method facilitates the editing of previously intractable genomic loci and small genetic elements.
- The approach has broad applicability across organisms supporting CRISPR/Cas and aids in complex genetic analyses.
Related Concept Videos
CRISPR/Cas9 Genome Editing
670
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
670
CRISPR
53.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.5K
CRISPR and crRNAs
17.9K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.9K
Homologous Recombination
55.8K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
55.8K

